Latest debt-to-equity ratio
Gain Therapeutics Debt-to-equity ratio
Direct answer
Gain Therapeutics's debt-to-equity ratio is 5.4%.
The verified market snapshot reports 5.4%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 19, 2026.
Get free Gain Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 5.4%
Explore related company data
View Gain Therapeutics's market capitalizationView Gain Therapeutics's price-to-book ratioView Gain Therapeutics's return on equityView Gain Therapeutics's dividend yieldView Gain Therapeutics's 52-week price rangeView Gain Therapeutics's profit marginView all Gain Therapeutics key metricsReturn to Gain Therapeutics profile